In vitro comparison of third-generation cephalosporins, piperacillin, dibekacin, and other aminoglycosides against aerobic bacteria.
The in vitro activities of four new beta-lactam antibiotics and dibekacin against aerobic bacteria were compared. The new cephalosporins were more broadly active against gram-negative bacteria than were presently available cephalosporins, but were less active against staphylococci.
D000617:Aminoglycosides / Q000494:pharmacology; D000900:Anti-Bacterial Agents / Q000494:pharmacology*; D001419:Bacteria / Q000187:drug effects*; D002511:Cephalosporins / Q000494:pharmacology*; D003982:Dibekacin / Q000494:pharmacology*; D007612:Kanamycin / Q000031:analogs & derivatives*; D008826:Microbial Sensitivity Tests; D010406:Penicillins / Q000494:pharmacology*; D010878:Piperacillin
D000617:Aminoglycosides; D000900:Anti-Bacterial Agents; D002511:Cephalosporins; D010406:Penicillins; D003982:Dibekacin; D007612:Kanamycin; D010878:Piperacillin